Choonhakarn C, Chetchotisakd P, Jirarattanapochai K, et al. Sweet’s syndrome associated with non-tuberculous mycobacterial infection: a report of fve cases. Br J Dermatol 1998;139(1):107-10.
hetchotisakd P, Mootsikapun P, Anunnatsiri S, et al. Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity.Clin Infect Dis 2000;30(1):29-34.
Mahaisavariya P, Chaiprasert A, Manonukul J, et al. Scrofuloderma and Sweet’s syndrome.Int J Dermatol 2002;41(1):28-31.
Sungkanuparph S, Sathapatayavongs B, Pracharktam R. Infections with rapidly growing mycobacteria: report of 20 cases.Int J Infect Dis 2003;7(3):198-205.
Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, et al. Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis 2007;45(4):421-7.
offnger R, Helbert MR, Barcenas-Morales G, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specifc autoimmunity.Clin Infect Dis 2004;38(1):e10-4
Hoflich C, Sabat R, Rosseau S, et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood 2004;103(2):673-5.
Patel SY, Ding L, Brown MR, et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol 2005;175(7):4769-76
Baerlecken N, Jacobs R, Stoll M, et al. Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-gamma autoantibody. Clin Infect Dis 2009;49(7):e76-8.
Koya T, Tsubata C, Kagamu H, et al. Anti-interferongamma autoantibody in a patient with disseminated Mycobacterium avium complex.J Infect Chemother 2009;15(2):118-22.
Tang BS, Chan JF, Chen M, , et al. Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodefciency due to autoantibody against gamma interferon. Clin Vaccine Immunol 2010;17(7):1132-8.
ampitak T, Suwanpimolkul G, Browne S, et al. Anti-interferon-gamma autoantibody and opportunistic infections: case series and review of the literature. Infection 2011;39(1):65-71.
rowne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodefciency in Thailand and Taiwan.N Engl J Med 2012;367(8):725-34.
Chaisathaphol T, Jitmuang A. Disseminated Mycobacterium avium and recurrent Salmonella group D infection in a patient with autoantibodies to interferon-gamma. Southeast Asian J Trop Med Public Health 2013;44(3):460-7.
Ishii T, Tamura A, Matsui H, et al. Disseminated Mycobacterium avium complex infection in a patient carrying autoantibody to interferon-gamma.J InfectChemother 2013;19(6):1152-7.
Nei T, Okabe M, Mikami I, et al. A non-HIV case with disseminated Mycobacterium kansasii disease associated with strong neutralizing autoantibody to interferon-gamma. Respir Med Rep 2013;8:10-3.
ongkulab P, Wipasa J, Chaiwarith R, et al. Autoantibody to interferon-gamma associated with adult-onset immunodefciency in non-HIV individuals in Northern Thailand. PloS one 2013;8(9):e76371.
DeLeon TT, Chung HH, Opal SM, et al. Mycobacterium avium complex empyema in a patient with interferon gamma autoantibodies.Hawai’i J Med Public Health 2014;73(9 Suppl 1):15-7.
O’Connell E, Rosen LB, LaRue RW, et al. The first US domestic report of disseminated Mycobacterium avium complex and anti-interferon-gamma autoantibodies.J Clin Immunol 2014;34(8):928-32.
Suzuki K, Terada J, Sasaki Y, Kawasaki T, et al. Pulmonary Mycobacterium fortuitum infection with cervical lymphadenitis in a patient carrying autoantibodies to interferon-gamma.Intern Med 2014;53(12):1361-4.
Hanitsch LG, Lobel M, Muller-Redetzky H, et al. Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies. J Clin Immunol 2015;35(4):361-5.
Hase I, Morimoto K, Sakagami T, et al. Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-gamma neutralizing autoantibodies.J Infect Chemother 2015;21(6):468-72.
Nishimura T, Fujita-Suzuki Y, Yonemaru M, et al. Recurrence of disseminated Mycobacterium avium complex disease in a patient with anti-gamma interferon autoantibodies by reinfection.J Clinical Microbiol 2015;53(4):1436-8.
Poulin S, Corbeil C, Nguyen M, et al. Fatal Mycobacterium colombiense/cytomegalovirus coinfection associated with acquired immunodefciency due to autoantibodies against interferon gamma: a case report. BMC Infect Dis 2013;13:24.
Chan JF, Yee KS, Tang BS, et al. Adult-onset immunodefciency due to anti-interferon-gamma autoantibody in mainland Chinese.Chin Med J (Eng) 2014;127(6):1189-90.
Valour F, Perpoint T, Senechal A, et al. Interferon-gamma Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection.Emerg Infect Dis 2016;22(6): 1124-6.
Haverkamp MH, van Dissel JT, Holland SM. Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling.Microbes Infect 2006;8(4):1157-66.
Gutierrez MG, Master SS, Singh SB, et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages.Cell 2004;119(6):753-66
Wu UI, Holland SM. Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis 2015;15(8):968-80.
van de Vosse E, Hoeve MA, Ottenhoff TH. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 2004;4(12):739-49.
Holland SM. Interferon gamma, IL-12, IL-12R and STAT-1 immunodefciency diseases: disorders of the interface of innate and adaptive immunity.Immunol Res 2007;38 (1-3):342-6.
Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 defciency. Clin Infect Dis2005;41(4):e38-41.
Vinh DC, Masannat F, Dzioba RB, et al. Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 defciency.Clin Infect Dis 2009;49(6):e62-5.
Sampaio EP, Hsu AP, Pechacek J, et al. Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis.J Allergy Clin Immunol 2013;131(6): 1624-34.
Picard C, Fieschi C, Altare F, et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds.Am J Hum Genet 2002;70(2): 336-48.
Prando C, Samarina A, Bustamante J, et al. Inherited IL-12p40 defciency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds.Medicine 2013;92(2):109-22.
Fieschi C, Dupuis S, Catherinot E, et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 defciency: medical and immunological implications.J Exp Med 2003;197(4):527-35.
Gruenberg DA, Anover-Sombke S, Gern JE, et al. Atypical presentation of IL-12 receptor beta1 defciency with pneumococcal sepsis and disseminated nontuberculous mycobacterial infection in a 19-month-old girl born to nonconsanguineous US residents.J Allergy Clin Immunol 2010;125(1):264-5.
Bogunovic D, Byun M, Durfee LA, et al. Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency.Science 2012;337(6102):1684-8.
Kilic SS, van Wengen A, de Paus RA, et al. Severe disseminated mycobacterial infection in a boy with a novel mutation leading to IFN-gammaR2 defciency.J Infect 2012;65(6):568-72.
Kong XF, Vogt G, Itan Y, et al. Haploinsuffciency at the human IFNGR2 locus contributes to mycobacterial disease. Hum Mol Genet 2013;22(4):769-81.
Kristensen IA, Veirum JE, Moller BK, et al. Novel STAT1 alleles in a patient with impaired resistance to mycobacteria. J Clin Immunol 2011;31(2):265-71.
Vairo D, Tassone L, Tabellini G, et al. Severe impairment of IFN-gamma and IFN-alpha responses in cells of a patient with a novel STAT1 splicing mutation.Blood 2011;118(7):1806-17.
Hambleton S, Salem S, Bustamante J, et al. IRF8 mutations and human dendritic-cell immunodefciency.N Engl J Med 2011;365(2):127-38.
Niehues T, Reichenbach J, Neubert J, et al. Nuclear factor kappaB essential modulator-defcient child with immunodefciency yet without anhidrotic ectodermal dysplasia.J Allergy Clin Immunol 2004;114(6):1456-62.
Niehues T, Reichenbach J, Neubert J, et al. Nuclear factor kappaB essential modulator-defcient child with immunodefciency yet without anhidrotic ectodermal dysplasia.J Allergy Clin Immunol 2004;114(6):1456-62.
Bustamante J, Arias AA, Vogt G, et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease.Nat Immunol 2011;12(3):213-21.
Filipe-Santos O, Bustamante J, Chapgier A, et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features.Semin Immunol 2006;18(6):347-61.
Ling KW, Ottersbach K, van Hamburg JP, et al. GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells.J Exp Med 2004;200(7): 871-82.
Vinh DC, Patel SY, Uzel G, et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia.Blood 2010;115(8):1519-29.
Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.Blood 2014;123(6):809-21.
Chi CY, Chu CC, Liu JP, et al. Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLADRB1*16:02 and HLA-DQB1*05:02 and the reactivationof latent varicella-zoster virus infection.Blood 2013;121(8):1357-66.
Pithukpakorn M, Roothumnong E, Angkasekwinai N, et al. HLA-DRB1 and HLA-DQB1 Are Associated with Adult-Onset Immunodefciency with Acquired AntiInterferon-Gamma Autoantibodies.PloS one 2015;10(5):e0128481
Picard C, Al-Herz W, Bousfha A, et al. Primary Immunodefciency Diseases: an Update on the Classifcation from the International Union of Immunological Societies Expert Committee for Primary Immunodefciency 2015.J Clin Immunol2015;35(8):696-726.
Chi CY, Lin CH, Ho MW, et al. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-gamma autoantibodies and disseminated nontuberculous mycobacterial infections.Medicine 2016;95(25):e3927.
Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol 2011;7:137-152
Lam DW, LeRoith D. The worldwide diabetes epidemic. Curr Opin Endocrinol Diabetes Obes 2012;19:93-96
Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:2672-2713